Latest Articles

Publication Date
Focaltherics™ announces the successful commercial launch of its Focal One® project for endometriosis in Europe, with treatment completed for the first group of patients. - Bitget

Focaltherics™ announces the successful commercial launch of its Focal One® project for endometriosis in Europe, with treatment completed for the first group of patients. Bitget

Published: June 30, 2026, 8:07 p.m.
FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients - Yahoo Finance

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients Yahoo Finance

Published: June 30, 2026, 11:30 a.m.
First European endometriosis Focal One program treats patients in France - Stock Titan

First European endometriosis Focal One program treats patients in France Stock Titan

Published: June 30, 2026, 11:30 a.m.
Patients with endometriosis have ‘distinct hormone fingerprint’ - Doctors.net.uk

Patients with endometriosis have ‘distinct hormone fingerprint’ Doctors.net.uk

Published: June 30, 2026, 9:30 a.m.
A new subsidized drug for patients with endometriosis - ipn.md

A new subsidized drug for patients with endometriosis ipn.md

Published: June 25, 2026, 8:09 a.m.
Covid-19: Person tests positive at Middlemore Hospital, 40 patients considered contacts - RNZ

Covid-19: Person tests positive at Middlemore Hospital, 40 patients considered contacts RNZ

Published: June 19, 2026, 7:29 a.m.
Several Covid-19 cases among patients at Porirua's Kenepuru Hospital - RNZ

Several Covid-19 cases among patients at Porirua's Kenepuru Hospital RNZ

Published: June 19, 2026, 5:08 a.m.
NEWS: Hypermobility Patients Waiting Up to 21 Years for Diagnosis - Practice Business

NEWS: Hypermobility Patients Waiting Up to 21 Years for Diagnosis Practice Business

Published: June 18, 2026, 10:23 a.m.
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR

Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR

Published: June 18, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Macau Business

Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Macau Business

Published: June 18, 2026, 7:26 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!